Micro Interventional Devices, Inc. (MID) was founded in 2010 by Michael P. Whitman. MID is a medical device company that designs, manufactures and commercializes disruptive technologies for use in percutaneous and minimally invasive structural heart repair procedures.
While the applications of MID’s technology are expansive, the Company is setting its initial sights on three important unmet needs in structural heart disease: access and closure, mitral and tricuspid valve repair and mitral valve replacement. Permaseal™, MIA™ and Permavalve™ will drive the revolution in catheter-based solutions to structural heart disease. MID is headquartered in Newtown, Pennsylvania.
MID intends to make Permaseal the new standard of care for safe and reliable access and closure during structural heart repair procedures.